Biogen Inc. (NASDAQ:BIIB) Q4 2022 Results Conference Call February 15, 2023 8:00 AM ET Company Participants Mike Hencke - Head, Investor Relations Christopher Viehbacher - CEO Michael McDonnell - Chief Financial Officer Priya Singhal - Interim Head, Research & Development Conference Call Participants Salveen Richter - Goldman Sachs Mohit Bansal - Wells Fargo Colin Bristow - UBS Umer Raffat - Evercore Evan Seigerman - BMO Tim Anderson - Wolfe Research Brian Abrahams - RBC Capital Markets Michael Yee - Jeffer ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 0-19311 BIOGEN INC. (Exact name of registrant as specified in its charter) Delaware 33-0112644 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identif ...

Biogen Inc. (NASDAQ:BIIB) 41st Annual J.P. Morgan Healthcare Conference Call January 9, 2023 2:15 PM ET Company Participants Chris Viehbacher - CEO Conference Call Participants Chris Schott - J.P. Morgan Chris Schott Good morning, everybody. I'm Chris Schott at J.P. Morgan. And it's my pleasure to be hosting a fireside chat with Chris Viehbacher, who joined Biogen Inc. a little bit less than two months ago as CEO. So, Chris, happy New Year, and thanks for joining us today. Chris Viehbacher Thanks, Chris. Ha ...

Biogen Inc. (NASDAQ:BIIB) Biogen and Sage Zuranolone Webcast December 6, 2022 8:00 AM ET Company Participants Helen Rubinstein - Director, Investor Relations, Sage Therapeutics Chris Benecchi - Chief Business Officer, Sage Therapeutics Maha Radhakrishnan - Group SVP and Chief Medical Officer, Biogen Greg Mattingly - Associate Clinical Professor, Washington University Alisha Alaimo - President of U.S. Organization, Biogen Mike Hencke - Head, Investor Relations, Biogen Jim Doherty - Chief Development Officer, ...

Biogen Inc. (NASDAQ:BIIB) 5th Annual Evercore ISI HealthCONx Conference Call December 1, 2022 10:30 AM ET Company Participants Mike McDonnell - Chief Financial Officer Priya Singhal - Head of Global Safety and Regulatory Sciences and Interim Head of R&D Conference Call Participants Umer Raffat - Evercore ISI Umer Raffat Hello, everyone. Pleasure to have Biogen management join us right after Merck and there’s a lot to talk about, but let me turn it over to you, Mike, to kick things off. Mike McDonnell Excell ...

Biogen Inc. (NASDAQ:BIIB) Q3 2022 Earnings Conference Call October 25, 2022 8:00 AM ET Company Participants Mike Hencke - Head, Investor Relations Michel Vounatsos - Chief Executive Officer Priya Singhal - Interim Head, Research & Development Michael McDonnell - Chief Financial Officer Conference Call Participants Umer Raffat - Evercore Brian Abrahams - RBC Capital Markets Salveen Richter - Goldman Sachs Tim Anderson - Wolfe Research Chris Raymond - Piper Sandler Matthew Harrison - Morgan Stanley Brian Skor ...